Cart
sales@molnova.com
PHA-680632
CAS No. 398493-79-3
PHA-680632( PHA680632 | PHA 680632 )
Catalog No. M14369 CAS No. 398493-79-3
A potent, highly selective Aurora kinase inhibitor with IC50 of 27, 135 and 120 nM for Aurora A, B and C, respectively.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 41 | In Stock |
|
| 5MG | 37 | In Stock |
|
| 10MG | 68 | In Stock |
|
| 25MG | 140 | In Stock |
|
| 50MG | 237 | In Stock |
|
| 100MG | 397 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NamePHA-680632
-
NoteResearch use only, not for human use.
-
Brief DescriptionA potent, highly selective Aurora kinase inhibitor with IC50 of 27, 135 and 120 nM for Aurora A, B and C, respectively.
-
DescriptionA potent, highly selective Aurora kinase inhibitor with IC50 of 27, 135 and 120 nM for Aurora A, B and C, respectively; exhibits at least 30- to 200-fold selectivity against a panel of 22 kinases compared with Aurora A; has potent antiproliferative activity in a wide range of cancer cell types (IC50=0.06-7.15 uM); shows significant tumor growth inhibition in different animal tumor models at well-tolerated doses.
-
In Vitro——
-
In Vivo——
-
SynonymsPHA680632 | PHA 680632
-
PathwayCell Cycle/DNA Damage
-
TargetAurora Kinase
-
RecptorAurora A| Aurora B| Aurora C| FGFR1| PLK1
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number398493-79-3
-
Formula Weight501.6232
-
Molecular FormulaC28H35N7O2
-
Purity>98% (HPLC)
-
SolubilityDMSO: ≥ 30 mg/mL
-
SMILESO=C(N(C1)CC2=C1C(NC(C3=CC=C(N4CCN(C)CC4)C=C3)=O)=NN2)NC5=C(CC)C=CC=C5CC
-
Chemical NamePyrrolo[3,4-c]pyrazole-5(1H)-carboxamide, N-(2,6-diethylphenyl)-4,6-dihydro-3-[[4-(4-methyl-1-piperazinyl)benzoyl]amino]-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Soncini C, et al. Clin Cancer Res. 2006 Jul 1;12(13):4080-9.
2. Tao Y, et al. Br J Cancer. 2007 Dec 17;97(12):1664-72.
3. Ratushny V, et al. Oncogene. 2012 Mar 8;31(10):1217-27.
molnova catalog
related products
-
AT-9283
A multi-targeted kinase inhibitor with potent activity against Aurora A, Aurora B, JAK2, JAK3, and ABL (T315I) with IC50 of 3, 3, 1.2, 1.1, and 4 nM, respectively.
-
SCH-1473759 hydrochl...
A potent, picomolar, dual inhibitor of Aurora A and B with IC50 of 0.02 and 0.03 nM, respectively; shows improved cell potency (phos-HH3 inhibition IC50=25 nM) and intrinsic aqueous solubility (11.4 mM).
-
CCT 137690
A potent, orally bioavailable Aurora kinases inhibitor with IC50 of 15/25/19 nM for Aurora A/B/C; displays antiproliferative activity in a range of human tumor cell lines, including SW620 colon carcinoma (GI50=0.30 uM) and A2780 ovarian cancer cell line (GI50=0.14 uM).
